Stock listing

Frankfurt:P0F Egetis Therapeutics AB Aktie

German listing (Frankfurt) of Egetis Therapeutics AB · home listing Stockholm:EGTX

Follow Egetis Therapeutics AB into a list and get an email when it puts out news.

Share price · FWB:P0F

€0.96 EUR -0.01 (-0.8%)

Close on Nov 20, 2026

Past year +120.5% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€0.96 – €0.964 EURNov 20, 2026
Market cap
€446.4M EURAt the close on Nov 20, 2026 · price × 465.0M shares outstanding
52-week range
€0.36 – €1.01 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€2,204 EURMedian day 0 shares · 47 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Egetis Therapeutics AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:EGTX · Home11.12 SEK-0.02 (-0.2%)1,812,09911.1211.1411.1211.14Close on Nov 20, 2026
LSE:0ABW11.14 SEK+0.01 (+0.1%)255,26211.1411.1511.1311.13Close on Nov 20, 2026
Frankfurt:P0F€0.96 EUR-0.008 (-0.8%)—€0.964€0.964€0.96€0.968Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:P0F · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.988+0.067+7.3%€0.988€0.997€0.9750
€0.921+0.04+4.5%€0.945€1.011€0.9140
€0.881+0.004+0.5%€0.877€0.883€0.8770
€0.877-0.002-0.2%€0.877€0.877€0.8770
€0.879-0.014-1.6%€0.88€0.891€0.8760
€0.893-0.01-1.1%€0.903€0.909€0.8862,120
€0.903+0.049+5.7%€0.906€0.907€0.9030
€0.854+0.012+1.4%€0.854€0.854€0.8542,860
€0.842+0.042+5.2%€0.80€0.842€0.7950
€0.80+0.002+0.3%€0.782€0.804€0.7790
€0.798-0.029-3.5%€0.798€0.798€0.7980
€0.827+0.032+4.0%€0.827€0.827€0.8270
€0.795+0.002+0.3%€0.795€0.795€0.7950
€0.793-0.007-0.9%€0.789€0.795€0.7880
€0.80+0.004+0.5%€0.80€0.80€0.800
€0.796-0.017-2.1%€0.796€0.796€0.7960
€0.813-0.021-2.5%€0.813€0.813€0.8130
€0.834-0.037-4.2%€0.834€0.834€0.8340
€0.871+0.02+2.4%€0.866€0.873€0.8650
€0.851-0.001-0.1%€0.851€0.851€0.8512,000
€0.852+0.029+3.5%€0.849€0.908€0.8452,000
€0.823+0.007+0.9%€0.823€0.823€0.8230
€0.816+0.039+5.0%€0.818€0.819€0.8130
€0.777-0.001-0.1%€0.777€0.777€0.7770
€0.778-0.004-0.5%€0.778€0.778€0.7780
€0.782-0.014-1.8%€0.798€0.807€0.7750
€0.796-0.006-0.7%€0.756€0.797€0.7560
€0.802+0.101+14.4%€0.719€0.804€0.71850
€0.701+0.079+12.7%€0.701€0.701€0.7010
€0.622-0.038-5.8%€0.66€0.693€0.6211,048
€0.66+0.005+0.8%€0.654€0.661€0.65318,000
€0.655-0.018-2.7%€0.655€0.655€0.6550
€0.673-0.003-0.4%€0.673€0.673€0.6690
€0.676+0.007+1.0%€0.647€0.678€0.6390
€0.669-0.009-1.3%€0.669€0.669€0.6690
€0.678+0.01+1.5%€0.678€0.678€0.6780
€0.668+0.005+0.8%€0.668€0.668€0.6680
€0.663-0.012-1.8%€0.663€0.663€0.6630
€0.675+0.006+0.9%€0.675€0.675€0.6750
€0.669-0.012-1.8%€0.669€0.669€0.6690
€0.681-0.008-1.2%€0.681€0.681€0.6810
€0.6890.000.0%€0.689€0.689€0.6890
€0.689-0.04-5.5%€0.694€0.698€0.6850
€0.729+0.025+3.6%€0.671€0.729€0.673,000
€0.704-0.006-0.8%€0.656€0.715€0.656270
€0.71+0.045+6.8%€0.681€0.711€0.671145,000
€0.665-0.013-1.9%€0.665€0.665€0.6650
€0.678+0.006+0.9%€0.678€0.678€0.6780
€0.672-0.012-1.8%€0.672€0.672€0.6720
€0.684-0.008-1.2%€0.684€0.684€0.6840
€0.692+0.006+0.9%€0.692€0.692€0.6920
€0.686+0.003+0.4%€0.686€0.686€0.6860
€0.683+0.037+5.7%€0.683€0.683€0.6830
€0.646+0.014+2.2%€0.646€0.646€0.6460
€0.632+0.047+8.0%€0.632€0.632€0.6320
€0.585-0.012-2.0%€0.585€0.585€0.5850
€0.597-0.005-0.8%€0.597€0.597€0.5970
Ticker
Frankfurt:P0F
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Egetis Therapeutics (Stockholm:EGTX) Q2 2026 Earnings Call

    Fri, Aug 21, 2026 · 8:00 AM ET

    Watch Transcript
  • Egetis Therapeutics (Stockholm:EGTX) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 4:00 AM ET

    Watch Transcript

Latest news

All Egetis Therapeutics AB news

Financings

  • Private placement of new ordinary shares

    Apr 21, 2026 · US$38.2M

    Closed: SEK 350M raised · SEK 5.25 a share · Stifel +2

    Dealers: Stifel (lead), Van Lanschot Kempen (co-lead), DNB Carnegie (co-lead)

    Buyers: Frazier Life Sciences (expected to anchor the Directed Issue); Invus; Woodline Partners; Parkman Healthcare Partners; Linc AB; The Fourth Swedish National Pension Fund; Cidro Förvaltning AB (Peter Lindell); Unionen

    Use of proceeds: Preparing Emcitate U.S. commercialization, RTH-beta indication expansion, working capital and general corporate purposes

    Announced Apr 21, 2026 · Closed Apr 21, 2026

Read by 6ix AI from the company's releases

Decks

Egetis Therapeutics AB on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
18 in the last 12 months · 18 in all · newest Sep 29, 2026 · oldest 2026
Calls
2 calls with a replay · 2 with a transcript · latest Aug 21, 2026
Decks
37 decks · latest October 2026

Where Egetis Therapeutics AB is listed

ListingExchangeCountryCurrency
Stockholm:EGTX · Home listingStockholmSwedenSEK
LSE:0ABWLSEUnited KingdomSEK
OTC:PDPHFOTCUnited StatesUSD
Lang & Schwarz:A1JH3BLang & SchwarzGermanyEUR
LS Exchange:A1JH3BLS ExchangeGermanyEUR
Frankfurt:P0F · This pageFrankfurtGermanyEUR
Aquis:EGTXSAquisUnited KingdomSEK
gettex:P0FgettexGermanyEUR
Aquis:EGTXSAquisUnited KingdomSEK
Munich:P0FMunichGermanyEUR
Stuttgart:P0FStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Egetis Therapeutics AB.